About Alt Biotech
Alt Biotech is a company based in Evry-courcouronnes (France) founded in 2023. It operates as a B2B. Alt Biotech operates in a competitive market with competitors including Multus, Metatissue, Nu-Tek Biosciences, Kohjin Bio and Sarvoshadhi Bio, among others.
- Headquarter Evry-courcouronnes, France
- SectorsHealthcare
- Website alt-biotech.com
Competitors of Alt Biotech
Alt Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multus, Metatissue, Nu-Tek Biosciences, Kohjin Bio and Sarvoshadhi Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| multus.bio | 2019 | London, United Kingdom | $9.3M | 8 | Provider of lab-grown meat alternatives | |
| metatissue.com | 2018 | Ilhavo, Portugal | – | – | Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications | |
| nu-tekbiosciences.com | 2008 | Minnetonka, United States | – | – | Develops innovative animal-free peptones and cell culture media for pharmaceutical use. | |
| kohjin-bio.jp | 1981 | Sakado, Japan | – | – | Tissue culture media provided for regenerative medicine and immunotherapy research. | |
| sarvoshadhi.com | 2017 | Kolhapur, India | – | – | Customized cell culture media for biotechnology are developed. | |
| metaboliq.ca | 2022 | Canada | – | – | Developer of cell culture medium for pharmaceutical screening and personalized medicine | |
| onkologic.com | 2021 | Farmington, United States | $305,000 | – | NK cell culture media is developed for cancer cell therapies. | |
| cet.bio | 2000 | Coralville, United States | $45,000 | – | Cell lines and stem cell products are supplied to researchers. |
Detailed competitors of Alt Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Alt Biotech
10 companies that operate in the same segment as Alt Biotech (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alt Biotech
Alt Biotech was founded in 2023.
Alt Biotech is headquartered in Evry-courcouronnes, France. It is registered at Evry-courcouronnes, Essonne, France.
Alt Biotech operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, cell culture, and recombinant proteins. Delivers comprehensive cell-culture solutions for producing non-therapeutic recombinant proteins. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Alt Biotech's top competitors include Multus, Onkologic and Cellular Engineering Technologies.